Shuyan Zhai

731 total citations
15 papers, 475 citations indexed

About

Shuyan Zhai is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Shuyan Zhai has authored 15 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Shuyan Zhai's work include Cancer Immunotherapy and Biomarkers (5 papers), Cancer Diagnosis and Treatment (2 papers) and Asthma and respiratory diseases (2 papers). Shuyan Zhai is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Cancer Diagnosis and Treatment (2 papers) and Asthma and respiratory diseases (2 papers). Shuyan Zhai collaborates with scholars based in United States, Australia and Germany. Shuyan Zhai's co-authors include Yana G. Najjar, Cindy Sander, John M. Kirkwood, Greg M. Delgoffe, Arivarasan Karunamurthy, Ashley V. Menk, Roma Bhatia, Roger D. Peng, Elizabeth C. Matsui and Amparito Cunningham and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Shuyan Zhai

15 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shuyan Zhai United States	10	145	130	127	96	74	15	475
Kari Brown United States	11	103 0.7×	195 1.5×	150 1.2×	34 0.4×	48 0.6×	25	551
Akhilesh Kaushal United States	12	35 0.2×	173 1.3×	90 0.7×	29 0.3×	75 1.0×	19	381
J Cunningham United States	9	92 0.6×	153 1.2×	25 0.2×	112 1.2×	68 0.9×	15	490
Amy Dresen United States	8	137 0.9×	222 1.7×	23 0.2×	88 0.9×	21 0.3×	14	473
Elizabeth J. Kopras United States	13	89 0.6×	209 1.6×	61 0.5×	38 0.4×	46 0.6×	29	599
Mei Tian China	10	74 0.5×	87 0.7×	207 1.6×	30 0.3×	18 0.2×	32	447
Bea Rutgers Netherlands	16	78 0.5×	281 2.2×	173 1.4×	187 1.9×	33 0.4×	33	892
Nathan Schoettler United States	11	52 0.4×	165 1.3×	292 2.3×	31 0.3×	24 0.3×	18	753
Rosemarie de la Rosa United States	5	90 0.6×	284 2.2×	17 0.1×	32 0.3×	69 0.9×	9	588
Prapaporn Kopsombut United States	12	53 0.4×	178 1.4×	75 0.6×	76 0.8×	153 2.1×	18	619

Countries citing papers authored by Shuyan Zhai

Since Specialization

Citations

This map shows the geographic impact of Shuyan Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuyan Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuyan Zhai more than expected).

Fields of papers citing papers by Shuyan Zhai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuyan Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuyan Zhai. The network helps show where Shuyan Zhai may publish in the future.

Co-authorship network of co-authors of Shuyan Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Shuyan Zhai. A scholar is included among the top collaborators of Shuyan Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuyan Zhai. Shuyan Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Tolcher, Anthony W., Michael S. Gordon, Kathleen M. Mahoney, et al.. (2023). Phase 1 first-in-human study of dalutrafusp alfa, an anti–CD73-TGF-β-trap bifunctional antibody, in patients with advanced solid tumors. Journal for ImmunoTherapy of Cancer. 11(2). e005267–e005267. 22 indexed citations

Augustin, Ryan C., Fei Ding, Shuyan Zhai, et al.. (2023). Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study. Frontiers in Oncology. 13. 1075823–1075823. 14 indexed citations

Mady, Leila J., Khalil Baddour, Shuyan Zhai, et al.. (2022). A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients. World Journal of Otorhinolaryngology - Head and Neck Surgery. 8(4). 345–354. 6 indexed citations

Kutsch, Nadine, Christian P. Pallasch, Eugen Tausch, et al.. (2022). Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia. HemaSphere. 6(4). e692–e692. 12 indexed citations

Eaglehouse, Yvonne L., Jill Brufsky, Shuyan Zhai, et al.. (2021). Effects of a personal trainer-led exercise intervention on physical activity, physical function, and quality of life of breast cancer survivors. Breast Cancer. 28(3). 737–745. 17 indexed citations

Nanivadekar, Ameya C., Derek M. Miller, Girish Chitnis, et al.. (2019). Machine learning prediction of emesis and gastrointestinal state in ferrets. PLoS ONE. 14(10). e0223279–e0223279. 13 indexed citations

Faden, Daniel L., Fei Ding, Yan Lin, et al.. (2019). APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma. Oral Oncology. 96. 140–147. 41 indexed citations

Najjar, Yana G., Ashley V. Menk, Cindy Sander, et al.. (2019). Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma. JCI Insight. 4(5). 171 indexed citations

Lotze, Michael T., et al.. (2019). Full adaptome repertoire analysis of immunotherapy to predict responsiveness and correlation with CD8-LAG3, sLAG3, and hepatocyte growth factor levels in patients with renal cancer.. Journal of Clinical Oncology. 37(15_suppl). e16116–e16116. 1 indexed citations

10.

Louis, Germaine M. Buck, Shuyan Zhai, Melissa M. Smarr, et al.. (2018). Endocrine disruptors and neonatal anthropometry, NICHD Fetal Growth Studies - Singletons. Environment International. 119. 515–526. 43 indexed citations

11.

Brigham, Emily, Elizabeth C. Matsui, Lawrence J. Appel, et al.. (2017). A pilot feeding study for adults with asthma: The healthy eating better breathing trial. PLoS ONE. 12(7). e0180068–e0180068. 4 indexed citations

12.

Zhai, Shuyan, et al.. (2017). Tolerance limits and tolerance intervals for ratios of normal random variables using a bootstrap calibration. Biometrical Journal. 59(3). 550–566. 6 indexed citations

13.

Matsui, Elizabeth C., Matthew S. Perzanowski, Roger D. Peng, et al.. (2017). Effect of an Integrated Pest Management Intervention on Asthma Symptoms Among Mouse-Sensitized Children and Adolescents With Asthma. JAMA. 317(10). 1027–1027. 79 indexed citations

14.

Sudini, Kuladeep, Gregory B. Diette, Patrick N. Breysse, et al.. (2016). A Randomized Controlled Trial of the Effect of Broccoli Sprouts on Antioxidant Gene Expression and Airway Inflammation in Asthmatics. The Journal of Allergy and Clinical Immunology In Practice. 4(5). 932–940. 39 indexed citations

15.

Zhai, Shuyan, Thomas Mathew, & Yi Huang. (2016). Comparison of drug dissolution profiles: a proposal based on tolerance limits. Statistics in Medicine. 35(29). 5464–5476. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact